Skip Navigation


Carcinogenesis Advance Access originally published online on June 15, 2005
Carcinogenesis 2005 26(11):1934-1939; doi:10.1093/carcin/bgi154
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
26/11/1934    most recent
bgi154v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kang, J. X.
Right arrow Articles by Li, F. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kang, J. X.
Right arrow Articles by Li, F. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis vol.26 no.11 © Oxford University Press 2005; all rights reserved.

The extract of huanglian, a medicinal herb, induces cell growth arrest and apoptosis by upregulation of interferon-ß and TNF-{alpha} in human breast cancer cells

Jing X. Kang *, Jing Liu, Jingdong Wang, Chengwei He and Frederick P. Li 1

Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA and 1 Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA

* To whom correspondence and reprints should be addressed at: Massachusetts General Hospital, Room 4433, 149 13th Street, Charlestown, MA 02129, USA. Tel: +1 617 726 8509; Fax: +1 617 726 6144; Email: kang.jing{at}mgh.harvard.edu

Huanglian (Coptidis rhizoma), a widely used herb in traditional Chinese medicine, has been shown recently to possess anticancer activities. However, the molecular mechanism underlying the anticancer effect of the herb is poorly understood. Specifically, whether huanglian extract affects the expression of cancer-related genes has not been defined. This study used DNA microarray technology to examine the effect of the herbal extract on expression of the common genes involved in carcinogenesis in two human breast cancer cell lines, the ER-positive MCF-7 and ER-negative MDA-MB-231 cells. Treatment of the cancer cells with huanglian extract markedly inhibited their proliferation in a dose- and time-dependent manner. The growth inhibitory effect was much more profound in MCF-7 cell line than that in MDA-MB-231 cells. DNA microarray assay revealed that treatment with huanglian dramatically increased the mRNA expression of interferon-ß (IFN-ß) and tumor necrosis factor-{alpha} in MCF-7 cells. Quantitative analysis by real-time PCR or western blotting confirmed the upregulation of the two genes (especially IFN-ß) in MCF-7 cells, but not in MDA-MB-231 cells. Addition of neutralizing antibody against IFN-ß to culture medium markedly inhibited the huanglian-induced antiproliferative effect, confirming the involvement of IFN-ß in the huanglian's effect and also suggesting an autocrine pathway for the action of IFN-ß in this setting. Given that IFN-ß is among the most important anticancer cytokines, the upregulation of this gene by huanglian is, at least in part, responsible for its antiproliferative effect. The results of this study implicate huanglian as a promising herb for chemoprevention and chemotherapy of certain cancers.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BloodHome page
J. W. Tyner, D. K. Walters, S. G. Willis, M. Luttropp, J. Oost, M. Loriaux, H. Erickson, A. S. Corbin, T. O'Hare, M. C. Heinrich, et al.
RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia
Blood, February 15, 2008; 111(4): 2238 - 2245.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.